Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Sponsored

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Posted

118

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Please log in to like, share and comment!

'You can't even blame this disaster on 70 years of Congress': Mallikarjun Kharge slams govt over Trump tariffs; calls Centre 'clueless'

By 0 11

Dry landslide blocks Mid-Hill Highway

LAMJUNG:A dry landslide has completely obstructed the Mid-Hill Highway at Bimire Bhanjyang in...

By 0 15

Gujarat govt to provide infrastructure aid to grant-in-aid schools under Mission School of Excellence 2.0

By 0 16

Bihar CM Nitish Kumar allows teachers to choose preferred districts after transfer complaints

By 0 16

Chennai GM: Playing hall unaffected despite fire issue, players back at venue

The Chennai Grand Masters chess tournament faced an unexpected disruption as a fire broke out at...

By 0 16